Anticarcinogenic effects of (-)-epigallocatechin gallate

Hirota Fujiki, Seiji Yoshizawa, Takahiko Horiuchi, Masami Suganuma, Jun Yatsunami, Shinji Nishiwaki, Sachiko Okabe, Rie Nishiwaki-Matsushima, Takuo Okuda, Takashi Sugimura

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Background. Our research objective is to develop nontoxic cancer chemopreventive agents and to apply these agents in treating humans. We are identifying agents that inhibit the process of tumor promotion in two-stage carcinogenesis experiments on mouse skin. Methods. We review (a) the inhibitory effect of penta-O-galloyl-β-d-glucose (5GG) on tumor promotion by teleocidin, one of the 12-O-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoters (5GG is structurally similar to (-)-epigallocatechin gallate (EGCG) and is isolated from hydrolyzed tannic acid); (b) the inhibitory effects of EGCG, the main constituent of Japanese green tea, on tumor promotion with two tumor promoters, teleocidin and okadaic acid, a non-TPA-type tumor promoter; (c) the mechanisms of action of EGCG, a single application of which reduced the specific binding of [3H]TPA and [3H]okadaic acid to a particulate fraction of mouse skin; and (d) the anticarcinogenic effects of EGCG on duodenal carcinogenesis induced by N-ethyl-N′-nitro-N-nitrosoguanidine in male C57BL/6 mice. EGCG is a nontoxic compound. Conclusion. We believe that the main constituent of Japanese green tea, EGCG, is a practical cancer chemopreventive agent available in everyday life.

Original languageEnglish
Pages (from-to)503-509
Number of pages7
JournalPreventive Medicine
Volume21
Issue number4
DOIs
Publication statusPublished - Jan 1 1992

Fingerprint

Anticarcinogenic Agents
Tetradecanoylphorbol Acetate
Carcinogens
Okadaic Acid
Tea
Neoplasms
Carcinogenesis
Skin
Rubiaceae
Tannins
Inbred C57BL Mouse
epigallocatechin gallate
Glucose
Research

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

Fujiki, H., Yoshizawa, S., Horiuchi, T., Suganuma, M., Yatsunami, J., Nishiwaki, S., ... Sugimura, T. (1992). Anticarcinogenic effects of (-)-epigallocatechin gallate. Preventive Medicine, 21(4), 503-509. https://doi.org/10.1016/0091-7435(92)90057-O

Anticarcinogenic effects of (-)-epigallocatechin gallate. / Fujiki, Hirota; Yoshizawa, Seiji; Horiuchi, Takahiko; Suganuma, Masami; Yatsunami, Jun; Nishiwaki, Shinji; Okabe, Sachiko; Nishiwaki-Matsushima, Rie; Okuda, Takuo; Sugimura, Takashi.

In: Preventive Medicine, Vol. 21, No. 4, 01.01.1992, p. 503-509.

Research output: Contribution to journalArticle

Fujiki, H, Yoshizawa, S, Horiuchi, T, Suganuma, M, Yatsunami, J, Nishiwaki, S, Okabe, S, Nishiwaki-Matsushima, R, Okuda, T & Sugimura, T 1992, 'Anticarcinogenic effects of (-)-epigallocatechin gallate', Preventive Medicine, vol. 21, no. 4, pp. 503-509. https://doi.org/10.1016/0091-7435(92)90057-O
Fujiki H, Yoshizawa S, Horiuchi T, Suganuma M, Yatsunami J, Nishiwaki S et al. Anticarcinogenic effects of (-)-epigallocatechin gallate. Preventive Medicine. 1992 Jan 1;21(4):503-509. https://doi.org/10.1016/0091-7435(92)90057-O
Fujiki, Hirota ; Yoshizawa, Seiji ; Horiuchi, Takahiko ; Suganuma, Masami ; Yatsunami, Jun ; Nishiwaki, Shinji ; Okabe, Sachiko ; Nishiwaki-Matsushima, Rie ; Okuda, Takuo ; Sugimura, Takashi. / Anticarcinogenic effects of (-)-epigallocatechin gallate. In: Preventive Medicine. 1992 ; Vol. 21, No. 4. pp. 503-509.
@article{8aa7b73ee77847edbfa0c9257310d8d3,
title = "Anticarcinogenic effects of (-)-epigallocatechin gallate",
abstract = "Background. Our research objective is to develop nontoxic cancer chemopreventive agents and to apply these agents in treating humans. We are identifying agents that inhibit the process of tumor promotion in two-stage carcinogenesis experiments on mouse skin. Methods. We review (a) the inhibitory effect of penta-O-galloyl-β-d-glucose (5GG) on tumor promotion by teleocidin, one of the 12-O-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoters (5GG is structurally similar to (-)-epigallocatechin gallate (EGCG) and is isolated from hydrolyzed tannic acid); (b) the inhibitory effects of EGCG, the main constituent of Japanese green tea, on tumor promotion with two tumor promoters, teleocidin and okadaic acid, a non-TPA-type tumor promoter; (c) the mechanisms of action of EGCG, a single application of which reduced the specific binding of [3H]TPA and [3H]okadaic acid to a particulate fraction of mouse skin; and (d) the anticarcinogenic effects of EGCG on duodenal carcinogenesis induced by N-ethyl-N′-nitro-N-nitrosoguanidine in male C57BL/6 mice. EGCG is a nontoxic compound. Conclusion. We believe that the main constituent of Japanese green tea, EGCG, is a practical cancer chemopreventive agent available in everyday life.",
author = "Hirota Fujiki and Seiji Yoshizawa and Takahiko Horiuchi and Masami Suganuma and Jun Yatsunami and Shinji Nishiwaki and Sachiko Okabe and Rie Nishiwaki-Matsushima and Takuo Okuda and Takashi Sugimura",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0091-7435(92)90057-O",
language = "English",
volume = "21",
pages = "503--509",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Anticarcinogenic effects of (-)-epigallocatechin gallate

AU - Fujiki, Hirota

AU - Yoshizawa, Seiji

AU - Horiuchi, Takahiko

AU - Suganuma, Masami

AU - Yatsunami, Jun

AU - Nishiwaki, Shinji

AU - Okabe, Sachiko

AU - Nishiwaki-Matsushima, Rie

AU - Okuda, Takuo

AU - Sugimura, Takashi

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Background. Our research objective is to develop nontoxic cancer chemopreventive agents and to apply these agents in treating humans. We are identifying agents that inhibit the process of tumor promotion in two-stage carcinogenesis experiments on mouse skin. Methods. We review (a) the inhibitory effect of penta-O-galloyl-β-d-glucose (5GG) on tumor promotion by teleocidin, one of the 12-O-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoters (5GG is structurally similar to (-)-epigallocatechin gallate (EGCG) and is isolated from hydrolyzed tannic acid); (b) the inhibitory effects of EGCG, the main constituent of Japanese green tea, on tumor promotion with two tumor promoters, teleocidin and okadaic acid, a non-TPA-type tumor promoter; (c) the mechanisms of action of EGCG, a single application of which reduced the specific binding of [3H]TPA and [3H]okadaic acid to a particulate fraction of mouse skin; and (d) the anticarcinogenic effects of EGCG on duodenal carcinogenesis induced by N-ethyl-N′-nitro-N-nitrosoguanidine in male C57BL/6 mice. EGCG is a nontoxic compound. Conclusion. We believe that the main constituent of Japanese green tea, EGCG, is a practical cancer chemopreventive agent available in everyday life.

AB - Background. Our research objective is to develop nontoxic cancer chemopreventive agents and to apply these agents in treating humans. We are identifying agents that inhibit the process of tumor promotion in two-stage carcinogenesis experiments on mouse skin. Methods. We review (a) the inhibitory effect of penta-O-galloyl-β-d-glucose (5GG) on tumor promotion by teleocidin, one of the 12-O-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoters (5GG is structurally similar to (-)-epigallocatechin gallate (EGCG) and is isolated from hydrolyzed tannic acid); (b) the inhibitory effects of EGCG, the main constituent of Japanese green tea, on tumor promotion with two tumor promoters, teleocidin and okadaic acid, a non-TPA-type tumor promoter; (c) the mechanisms of action of EGCG, a single application of which reduced the specific binding of [3H]TPA and [3H]okadaic acid to a particulate fraction of mouse skin; and (d) the anticarcinogenic effects of EGCG on duodenal carcinogenesis induced by N-ethyl-N′-nitro-N-nitrosoguanidine in male C57BL/6 mice. EGCG is a nontoxic compound. Conclusion. We believe that the main constituent of Japanese green tea, EGCG, is a practical cancer chemopreventive agent available in everyday life.

UR - http://www.scopus.com/inward/record.url?scp=0026705537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026705537&partnerID=8YFLogxK

U2 - 10.1016/0091-7435(92)90057-O

DO - 10.1016/0091-7435(92)90057-O

M3 - Article

C2 - 1409491

AN - SCOPUS:0026705537

VL - 21

SP - 503

EP - 509

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

IS - 4

ER -